Terms: = Skin cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
292 results:
1. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
[TBL] [Abstract] [Full Text] [Related]
2. GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
Jeong H; Cho YR; Gim J; Cha SK; Kim M; Kang DR
PLoS One; 2024; 19(3):e0291223. PubMed ID: 38536842
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Social Vulnerabilities of Care and prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
4. Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma.
Yun HY
Medicine (Baltimore); 2024 Feb; 103(8):e37183. PubMed ID: 38394487
[TBL] [Abstract] [Full Text] [Related]
5. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy.
Jacques SK; McKeown J; Grover P; Johnson DB; Zaremba A; Dimitriou F; Weiser R; Farid M; Namikawa K; Sullivan RJ; Rutkowski P; Lebbe C; Hamid O; Zager JS; Michielin O; Neyns B; Nakamura Y; Robert C; Mehnert J; Ascierto PA; Bhave P; Park B; Zimmer L; Mangana J; Mooradian M; Placzke J; Allayous C; Glitza Oliva IC; Mehmi I; Depalo D; Wicky A; Schwarze JK; Roy S; Boatwright C; Vanella V; Long GV; Menzies AM; Lo SN; Carlino MS
Eur J Cancer; 2024 Mar; 199():113563. PubMed ID: 38278007
[TBL] [Abstract] [Full Text] [Related]
7. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Mandalà M; Lorigan P; Sergi MC; Benannoune N; Serra P; Vitale MG; Giannarelli D; Arance AM; Couselo EM; Neyns B; Tucci M; Guida M; Spagnolo F; Rossi E; Occelli M; Queirolo P; Quaglino P; Depenni R; Merelli B; Placzke J; Di Giacomo AM; Del Vecchio M; Indini A; da Silva IP; Menzies AM; Long GV; Robert C; Rutkowski P; Ascierto PA
Eur J Cancer; 2024 Mar; 199():113542. PubMed ID: 38266540
[TBL] [Abstract] [Full Text] [Related]
8. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
[TBL] [Abstract] [Full Text] [Related]
9. Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung cancer.
Shimizu A; Fukasawa M; Mitani K; Goto K; Wakamoto A; Hatsuyama T; Hoshi T; Hasegawa I; Sato H
In Vivo; 2024; 38(1):418-424. PubMed ID: 38148096
[TBL] [Abstract] [Full Text] [Related]
10. Analysis and prediction of 5-year survival in patients with cutaneous melanoma: a model-based period analysis.
Zheng S; Yu H; Zheng X; Wu UT; Ming WK; Huang H; Song J; Zhang X; Lyu J; Deng L
Front Endocrinol (Lausanne); 2023; 14():1238086. PubMed ID: 38125787
[TBL] [Abstract] [Full Text] [Related]
11. An ensemble-based deep learning model for detection of mutation causing cutaneous melanoma.
Ali Shah A; Shaker ASA; Jabbar S; Abbas Q; Al-Balawi TS; Celebi ME
Sci Rep; 2023 Dec; 13(1):22251. PubMed ID: 38097641
[TBL] [Abstract] [Full Text] [Related]
12. RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma.
Jiang Y; Hu X; Wang Z; Zhang Q; Chen D; Zhao P
Invest New Drugs; 2024 Feb; 42(1):60-69. PubMed ID: 38071684
[TBL] [Abstract] [Full Text] [Related]
13. Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.
Chan JYY; Lam SC; Yuen HKL
Hong Kong Med J; 2023 Dec; 29(6):506-513. PubMed ID: 38044329
[TBL] [Abstract] [Full Text] [Related]
14. Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.
De Logu F; Ugolini F; Iannone LF; Simi S; Maio V; de Giorgi V; Maria di Giacomo A; Miracco C; Cossu A; Palmieri G; Mandalà M; Massi D
Lab Invest; 2023 Dec; 103(12):100259. PubMed ID: 37839638
[TBL] [Abstract] [Full Text] [Related]
15. Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases.
Fernandez JM; Koblinski JE; Dahak S; Curiel-Lewandrowski C; Thiede R
J Am Acad Dermatol; 2024 Feb; 90(2):280-287. PubMed ID: 37802183
[TBL] [Abstract] [Full Text] [Related]
16. Management of eyelids' primary malignancies.
Zgolli H; Choura R; Elzarrug HKH; Abdelhedi C; Chebbi A
Libyan J Med; 2023 Dec; 18(1):2258668. PubMed ID: 37731362
[No Abstract] [Full Text] [Related]
17. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
[TBL] [Abstract] [Full Text] [Related]
18. PRAME expression in cutaneous melanoma does not correlate with disease-specific survival.
Parra O; Ma W; Li Z; Coffing BN; Linos K; LeBlanc RE; Momtahen S; Sriharan A; Cloutier JM; Wells WA; Yan S
J Cutan Pathol; 2023 Oct; 50(10):903-912. PubMed ID: 37430414
[TBL] [Abstract] [Full Text] [Related]
19. Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase.
Pelizzari G; Bertoli E; Buriolla S; Vitale MG; Basile D; Palmero L; Zara D; Iacono D; Andrea F; Pascoletti G; Bolzonello S; Garutti M; Fasola G; Puglisi F; Minisini AM
Melanoma Res; 2023 Oct; 33(5):398-405. PubMed ID: 37402350
[TBL] [Abstract] [Full Text] [Related]
20. The Association Between Pregnancy Timing and Cumulative Exposure on Survival in Melanoma.
Bateni SB; Sutradhar R; Everett K; Wright FC; Hong NJL
Ann Surg Oncol; 2023 Oct; 30(11):6332-6338. PubMed ID: 37386307
[TBL] [Abstract] [Full Text] [Related]
[Next]